Hims & Hers Health stock has seen its consensus analyst price target decrease from $47.42 to $46.67 per share. This shift comes as analysts weigh ongoing opportunities for growth against signals of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果